205 related articles for article (PubMed ID: 18801310)
1. A study of intestinal absorption of bicyclol in rats: active efflux transport and metabolism as causes of its poor bioavailability.
Tan W; Chen H; Zhao J; Hu J; Li Y
J Pharm Pharm Sci; 2008; 11(3):97-105. PubMed ID: 18801310
[TBL] [Abstract][Full Text] [Related]
2. [Effect of CYP3A and P-glycoprotein on the absorption of buagafuran in rat intestinal lumen].
Sheng L; Tan W; Hu JP; Chen H; Li Y
Yao Xue Xue Bao; 2010 Jan; 45(1):43-8. PubMed ID: 21351448
[TBL] [Abstract][Full Text] [Related]
3. Role of P-glycoprotein in the intestinal absorption of tanshinone IIA, a major active ingredient in the root of Salvia miltiorrhiza Bunge.
Yu XY; Lin SG; Zhou ZW; Chen X; Liang J; Liu PQ; Duan W; Chowbay B; Wen JY; Li CG; Zhou SF
Curr Drug Metab; 2007 May; 8(4):325-40. PubMed ID: 17504222
[TBL] [Abstract][Full Text] [Related]
4. Enhanced intestinal absorption of etoposide by self-microemulsifying drug delivery systems: roles of P-glycoprotein and cytochrome P450 3A inhibition.
Zhao G; Huang J; Xue K; Si L; Li G
Eur J Pharm Sci; 2013 Nov; 50(3-4):429-39. PubMed ID: 23981337
[TBL] [Abstract][Full Text] [Related]
5. P-glycoprotein and cytochrome P450 3A act together in restricting the oral bioavailability of paclitaxel.
Hendrikx JJ; Lagas JS; Rosing H; Schellens JH; Beijnen JH; Schinkel AH
Int J Cancer; 2013 May; 132(10):2439-47. PubMed ID: 23090875
[TBL] [Abstract][Full Text] [Related]
6. Dextran sulfate sodium-induced colitis and ginseng intervention altered oral pharmacokinetics of cyclosporine A in rats.
Yang Y; Hu N; Gao XJ; Li T; Yan ZX; Wang PP; Wei B; Li S; Zhang ZJ; Li SL; Yan R
J Ethnopharmacol; 2021 Jan; 265():113251. PubMed ID: 32810615
[TBL] [Abstract][Full Text] [Related]
7. Effect of pluronic P123 and F127 block copolymer on P-glycoprotein transport and CYP3A metabolism.
Guan Y; Huang J; Zuo L; Xu J; Si L; Qiu J; Li G
Arch Pharm Res; 2011 Oct; 34(10):1719-28. PubMed ID: 22076772
[TBL] [Abstract][Full Text] [Related]
8. Grapefruit juice activates P-glycoprotein-mediated drug transport.
Soldner A; Christians U; Susanto M; Wacher VJ; Silverman JA; Benet LZ
Pharm Res; 1999 Apr; 16(4):478-85. PubMed ID: 10227700
[TBL] [Abstract][Full Text] [Related]
9. [Transport of limonin in rat intestine in situ and Caco-2 cells in vitro].
Zhang XY; Ke X; He L; Tian JL
Yao Xue Xue Bao; 2012 Feb; 47(2):229-32. PubMed ID: 22512036
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the Role of P-glycoprotein (P-gp)-Mediated Efflux in the Intestinal Absorption of Common Substrates with Elacridar, a P-gp Inhibitor, in Rats.
Suzuki K; Taniyama K; Aoyama T; Watanabe Y
Eur J Drug Metab Pharmacokinet; 2020 Jun; 45(3):385-392. PubMed ID: 32078103
[TBL] [Abstract][Full Text] [Related]
11. Effects of myricetin on the bioavailability of doxorubicin for oral drug delivery in rats: possible role of CYP3A4 and P-glycoprotein inhibition by myricetin.
Choi SJ; Shin SC; Choi JS
Arch Pharm Res; 2011 Feb; 34(2):309-15. PubMed ID: 21380815
[TBL] [Abstract][Full Text] [Related]
12. Role of P-glycoprotein in intestinal absorption of FB2, a promising Abl/Src dual tyrosine kinase inhibitor.
Huang K; Hu J; Li X; Li Y
Drug Metab Pharmacokinet; 2012; 27(5):486-94. PubMed ID: 22447116
[TBL] [Abstract][Full Text] [Related]
13. Intestinal metabolism promotes regional differences in apical uptake of indinavir: coupled effect of P-glycoprotein and cytochrome P450 3A on indinavir membrane permeability in rat.
Li LY; Amidon GL; Kim JS; Heimbach T; Kesisoglou F; Topliss JT; Fleisher D
J Pharmacol Exp Ther; 2002 May; 301(2):586-93. PubMed ID: 11961060
[TBL] [Abstract][Full Text] [Related]
14. In vivo modulation of intestinal CYP3A metabolism by P-glycoprotein: studies using the rat single-pass intestinal perfusion model.
Cummins CL; Salphati L; Reid MJ; Benet LZ
J Pharmacol Exp Ther; 2003 Apr; 305(1):306-14. PubMed ID: 12649383
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the Effects of Maytenus ilicifolia on the Activities of Cytochrome P450 3A and P-glycoprotein.
do Nascimento SB; de Lima Nascimento M; de Araújo LL; de Oliveira FM; do Carmo Vieira M; Duarte-Almeida JM; Siqueira JM; da Costa César I; Derendorf H; de Castro WV
Curr Drug Metab; 2020; 21(4):281-290. PubMed ID: 32394829
[TBL] [Abstract][Full Text] [Related]
16. Effects of cyclosporine A and itraconazole on permeability, biliary excretion and pharmacokinetics of amlodipine.
Ni L; Yu X; Yu Q; Chen X; Jia L
Drug Metab Lett; 2008 Aug; 2(3):163-8. PubMed ID: 19356088
[TBL] [Abstract][Full Text] [Related]
17. In silico modeling for the nonlinear absorption kinetics of UK-343,664: a P-gp and CYP3A4 substrate.
Abuasal BS; Bolger MB; Walker DK; Kaddoumi A
Mol Pharm; 2012 Mar; 9(3):492-504. PubMed ID: 22264132
[TBL] [Abstract][Full Text] [Related]
18. Effects of quercetin on the bioavailability of doxorubicin in rats: role of CYP3A4 and P-gp inhibition by quercetin.
Choi JS; Piao YJ; Kang KW
Arch Pharm Res; 2011 Apr; 34(4):607-13. PubMed ID: 21544726
[TBL] [Abstract][Full Text] [Related]
19. Short-chain fatty acids oppositely altered expressions and functions of intestinal cytochrome P4503A and P-glycoprotein and affected pharmacokinetics of verapamil following oral administration to rats.
Zhang J; Xie Q; Kong W; Wang Z; Wang S; Zhao K; Chen Y; Liu X; Liu L
J Pharm Pharmacol; 2020 Mar; 72(3):448-460. PubMed ID: 31863502
[TBL] [Abstract][Full Text] [Related]
20. Enhanced Oral Bioavailability of Domperidone with Piperine in Male Wistar Rats: Involvement of CYP3A1 and P-gp Inhibition.
Athukuri BL; Neerati P
J Pharm Pharm Sci; 2017; 20():28-37. PubMed ID: 28459658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
